Olema Pharmaceuticals, Inc. (OLMA)
25.36
+0.35
(+1.40%)
USD |
NASDAQ |
Feb 06, 16:00
25.34
-0.02
(-0.06%)
After-Hours: 20:00
Olema Pharmaceuticals SG&A Expense (TTM) : 18.61M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Cidara Therapeutics, Inc. | 28.09M |
| Cogent Biosciences, Inc. | 51.34M |
| Corvus Pharmaceuticals, Inc. | 9.105M |
| Genprex, Inc. | 6.261M |